← Open Payments lookup

TERRY NEVILLE: Open Payments

NPI 1457336083 · FORT GEORGE G MEADE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,639 in 118 payments from 12 companies in 2025. Trend: 2023 $842 · 2024 $1,265 · 2025 $2,639

Food & beverage: $2,615Education: $24
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.17$502
Lundbeck LLC20$408
Janssen Pharmaceuticals, Inc10$368
Neurocrine BioSciences, Inc.10$279
Alkermes, Inc.21$249
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$198
ABBVIE INC.8$183
Teva Pharmaceuticals USA, Inc.9$156
Axsome Therapeutics, Inc.5$109
E.R. Squibb & Sons, L.L.C.4$86

Products named: INVEGA SUSTENNA, FANAPT, INGREZZA, ABILIFY ASIMTUFII, ARISTADA, CAPLYTA, HETLIOZ, VRAYLAR.

Industry payments across MD — which companies pay providers there.